&nbsp;

HPV_Slide_QR.jpg

Feb 2025

Document

HPV_Poster_FR.pdf

Feb 2025

Document

HPV_Postcard_FR.pdf

Feb 2025

Document

HPV_Slide_FR.jpg

Feb 2025

Document

CART-cellTherapyforAdult RelapsedrefractoryLymphomaThirdorSubsequentLine.pdf

Apr 2025

Document

CART-cellTherapyforAdultRelapsedrefractoryLymphomaThirdorSubsequentLine.pdf

Apr 2025

Document

ClearCellOvarianCancerTreatmentPathwayMap.pdf

Apr 2025

Regimen

CRBPPACL+PEMB

Cancer Type:

Gynecologic,

Endometrial

Intent: Adjuvant, Curative, Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) and Prior Ipilimumab

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CISPPEME+PEMB

Cancer Type:

Gastrointestinal,

Mesothelioma (Peritoneal),

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen

CRBPPEME+PEMB

Cancer Type:

Gastrointestinal,

Mesothelioma (Peritoneal),

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen

CRBPPACL+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - (Neo)adjuvant Therapy for Resectable Non-Small Cell Lung Cancer

Drugs Used: